Evidence map›Paper›PMID 24550453›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms.

Matthew Owens, Joe Herbert, Peter B Jones, Barbara J Sahakian, Paul O Wilkinson, Valerie J Dunn, Timothy J Croudace, Ian M Goodyer

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Neurobiology of resilience to early life stress.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Obesity and psychological distress.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  12. Stress Biomarkers in Black Youth: Exploring Psychological, Behavioral, and Socio-Ecological Correlates.Journal of urban health : bulletin of the New York Academy of Medicine · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Nature-Based Meditation, Rumination and Mental Wellbeing.International journal of environmental research and public health · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Matthew OwensDevelopmental and Lifecourse Research Group, Department of Psychiatry, University of Cambridge, Cambridge CB2 8AH, United Kingdom.
Joe Herbert
Peter B Jones
Barbara J Sahakian
Paul O Wilkinson
Valerie J Dunn
Timothy J Croudace
Ian M Goodyer
National Health Service · GBNational Institute for Health Research · GBUniversity of Cambridge · GBUniversity of York · GBWellcome Trust · GB

Funding

Department of Health 06/05/01Department of Health 97/29/01Medical Research Council G0001354Medical Research Council MC_PC_13042Medical Research Council MR/K006665/1Wellcome Trust 03/302Wellcome Trust 095844
6 · The paper itself

Abstract

Major depressive disorder (MD) is a debilitating public mental health problem with severe societal and personal costs attached. Around one in six people will suffer from this complex disorder at some point in their lives, which has shown considerable etiological and clinical heterogeneity. Overall there remain no validated biomarkers in the youth population at large that can aid the detection of at-risk groups for depression in general and for boys and young men in particular. Using repeated measurements of two well-known correlates of MD (self-reported current depressive symptoms and early-morning cortisol), we undertook a population-based investigation to ascertain subtypes of adolescents that represent separate longitudinal phenotypes. Subsequently, we tested for differential risks for MD and other mental illnesses and cognitive differences between subtypes. Through the use of latent class analysis, we revealed a high-risk subtype (17% of the sample) demarcated by both high depressive symptoms and elevated cortisol levels. Membership of this class of individuals was associated with increased levels of impaired autobiographical memory recall in both sexes and the greatest likelihood of experiencing MD in boys only. These previously unidentified findings demonstrate at the population level a class of adolescents with a common physiological biomarker specifically for MD in boys and for a mnemonic vulnerability in both sexes. We suggest that the biobehavioral combination of high depressive symptoms and elevated morning cortisol is particularly hazardous for adolescent boys.

Indexed as

AdolescentBiomarkersCohort StudiesDepressionEnglandFemaleHumansHydrocortisoneMajor Depressive DisorderMaleOdds RatioRegression AnalysisRisk FactorsBiomarkersHydrocortisoneadolescencegender differences

Identifiers

PMID24550453
PMCPMC3948242
OpenAlexW2107422785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.